The FDA sent a warning letter to EPH Technologies, accusing it of marketing and selling unapproved drugs.
A PROJECT OF:
This program is funded wholly, or in part, by the Government of the District of Columbia, DC Health, HIV/AIDS, Hepatitis, STD, TB Administration (HAHSTA).